Case study

16 Dec 2020

TFS involved in European global customer’s pre-launch activities


Overview

TFS was requested to prepare and conduct a Late Phase global proposal to support the pre-launch activities of two products in different Therapeutic Areas. This proposal was included in the European Strategic Action Program as part of the products’ Marketing Plan.


    Challenges

    • Offered different Late Phase study proposals considering different scenarios (type of study, target of population and specialist) ensuring alignment with the customer’s established strategic plan
    • Provided valuable scientific study designs in order to enhance the product and/or therapeutic indication knowledge during the pre-launch phase of products
    • Delivered an integrated solution to meet the client’s needs involving different company stakeholders
    • Ran the International Late Phase projects within the limited timelines due to products’ launch, despite challenging recruitment and a restrictive inclusion criteria

    See Other Case Studies

    How TFS Strategic Resourcing Solutions deployed a ...

    Given the catastrophic spread of COVID-19, the search for safe and effective therapies has taken on an unpreced...

    Read more

    TFS & a Global Biotech Company

    As clinical trials grow increasingly complex, timelines shorten, and R&D costs soar. Today’s biopharmaceuti...

    Read more

    Rescue of 'At-Risk' Trial H5N1 Vaccine Study / Hea...

    The complexities of coordinated enrollment to meet or exceed timelines are inherent with vaccine trials. Equally esse...

    Read more